Cargando…

Obesity, Insulin Resistance and Cancer Risk

Obesity is a known cause of metabolic syndrome which includes Type II diabetes, hypertension, and dyslipidemia. It is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension....

Descripción completa

Detalles Bibliográficos
Autores principales: Jee, Sun Ha, Kim, Hee Jin, Lee, Jakyoung
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815827/
https://www.ncbi.nlm.nih.gov/pubmed/16127767
http://dx.doi.org/10.3349/ymj.2005.46.4.449
_version_ 1782177055856656384
author Jee, Sun Ha
Kim, Hee Jin
Lee, Jakyoung
author_facet Jee, Sun Ha
Kim, Hee Jin
Lee, Jakyoung
author_sort Jee, Sun Ha
collection PubMed
description Obesity is a known cause of metabolic syndrome which includes Type II diabetes, hypertension, and dyslipidemia. It is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension. Both obesity and diabetes are emerging topics for researchers to consider as having a possible causal association with cancer since the two factors have been viewed as risk factors for cancer. The present paper introduced the hypothesis of a possible causal relationship between obesity, insulin resistance and cancer and reviews relevant existing studies in this area. More efforts and studies are needed to clarify the mechanisms and the common risk factors which might be incorporated into interventions to prevent cancer and cardiovascular diseases as top causes of death.
format Text
id pubmed-2815827
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-28158272010-02-04 Obesity, Insulin Resistance and Cancer Risk Jee, Sun Ha Kim, Hee Jin Lee, Jakyoung Yonsei Med J Review Article Obesity is a known cause of metabolic syndrome which includes Type II diabetes, hypertension, and dyslipidemia. It is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension. Both obesity and diabetes are emerging topics for researchers to consider as having a possible causal association with cancer since the two factors have been viewed as risk factors for cancer. The present paper introduced the hypothesis of a possible causal relationship between obesity, insulin resistance and cancer and reviews relevant existing studies in this area. More efforts and studies are needed to clarify the mechanisms and the common risk factors which might be incorporated into interventions to prevent cancer and cardiovascular diseases as top causes of death. Yonsei University College of Medicine 2005-08-31 2005-08-31 /pmc/articles/PMC2815827/ /pubmed/16127767 http://dx.doi.org/10.3349/ymj.2005.46.4.449 Text en Copyright © 2005 The Yonsei University College of Medicine http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Jee, Sun Ha
Kim, Hee Jin
Lee, Jakyoung
Obesity, Insulin Resistance and Cancer Risk
title Obesity, Insulin Resistance and Cancer Risk
title_full Obesity, Insulin Resistance and Cancer Risk
title_fullStr Obesity, Insulin Resistance and Cancer Risk
title_full_unstemmed Obesity, Insulin Resistance and Cancer Risk
title_short Obesity, Insulin Resistance and Cancer Risk
title_sort obesity, insulin resistance and cancer risk
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815827/
https://www.ncbi.nlm.nih.gov/pubmed/16127767
http://dx.doi.org/10.3349/ymj.2005.46.4.449
work_keys_str_mv AT jeesunha obesityinsulinresistanceandcancerrisk
AT kimheejin obesityinsulinresistanceandcancerrisk
AT leejakyoung obesityinsulinresistanceandcancerrisk